Importantly, we observed that the decrease in tumor growth induced by the overexpression of ORF3 was still observed in RGS16 KO mice, demonstrating that an RGS16 expression around the tumor is not required for ORF3 antitumoral activity. This evidence concerns the gene ASZ1 and neoplasm.